💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

White House plans to send millions of vaccine doses to retail pharmacies

Published 02/02/2021, 01:45 PM
Updated 02/02/2021, 02:40 PM
© Reuters. Coronavirus vaccination site at NYCHA housing complex in Brooklyn
PFE
-
CVS
-

By Trevor Hunnicutt and Carl O'Donnell

WASHINGTON (Reuters) - The White House next week will start shipping coronavirus vaccines directly to retail pharmacies alongside ongoing deliveries to states, increasing weekly supplies of shots nationwide to 11.5 million, a top aide said on Tuesday.

U.S. President Joe Biden's COVID-19 response coordinator, Jeff Zients, said the program will launch on Feb. 11 and will make 1 million doses available to 6,500 stores. As supply grows, the program could expand to as many as 40,000 stores, he said.

Biden said last month that the COVID-19 vaccine rollout has been a "dismal failure" so far and vowed to boost the speed at which shots are given to Americans, with a focus on ensuring equitable access regardless of geography, race, or ethnicity.

The Trump administration in November announced it had partnered with 19 pharmacy chains and networks nationwide - including CVS Health Corp (NYSE:CVS) and Walgreens Boots Alliance (NASDAQ:WBA) Inc - to begin distributing COVID-19 vaccines as they became available.

The federal government will distribute a million vaccine doses to the 6,500 stores next week, Zients said, adding that the amount will grow over time.

That is in addition to 10.5 million doses that the federal government plans to ship weekly to states and territories for the next three weeks, he added.

"This will provide more sites for people to get vaccinated in their communities," Zients said, adding that supply constraints will limit the program in its early days.

The initial pharmacy locations were selected to improve access to vaccines in hard to reach areas and among socially vulnerable communities, Zients said.

CVS said in a news release that its pharmacies will be participating in the program. It will receive 250,000 doses directly from the federal government for its initial rollout, CVS said, adding that it has capacity to provide 20 million to 25 million doses per month in total.

Zients also said the Federal Emergency Management Agency (FEMA) will reimburse states for some COVID-related costs they had taken on since the U.S. coronavirus outbreak began last January, such as for personal protective equipment and deployment of the national guard.

He said Congress does not need to approve funds for FEMA to do this and that the total payments to states will be between $3 billion and $5 billion.

Zients added that the federal government has acquired supplies of equipment healthcare providers need to get six doses from each vial of Pfizer Inc (NYSE:PFE)'s COVID-19 vaccine rather than five.

The Biden administration has said it is willing to use emergency wartime powers if necessary to secure the specialized low dead space syringes and other supplies needed to eliminate vaccine waste and improve administration efficiency.

© Reuters. Coronavirus vaccination site at NYCHA housing complex in Brooklyn

The major winter storm that hit the east coast of the United States this week has not disrupted vaccine deliveries but has forced some vaccine administration sites to shut down or reduce operating hours, Zients said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.